Your browser doesn't support javascript.
Impact of COVID-19 Disease in Early Breast Cancer Management: A Summary of the Current Evidence.
Cavalcante, Francisco Pimentel; Abdala, Edson; Weissmann, Leonardo; Ferreira, Carlos Eduardo Dos Santos; Amorim, Gilberto; de Oliveira, Vilmar Marques; Guilgen, Gisah; Landeiro, Luciana; Pinho, João Renato Rebello; Pulchinelli, Álvaro; Ribeiro, Heber; Souza, Rafael; Rosa, Daniela Dornelles.
  • Cavalcante FP; Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil.
  • Abdala E; Department of Infectious and Parasitic Diseases, School of Medicine, University of São Paulo (USP), São Paulo, SP, Brazil.
  • Weissmann L; Emílio Ribas Infectious Disease Institute, São Paulo, SP, Brazil.
  • Ferreira CEDS; Unaerp School of Medicine, Guarujá, SP, Brazil.
  • Amorim G; Brazilian Society of Infectology, São Paulo, SP, Brazil.
  • de Oliveira VM; Albert Einstein Hospital, São Paulo, SP, Brazil.
  • Guilgen G; Brazilian Society of Clinical Pathology/Laboratory Medicine, Rio de Janeiro, RJ, Brazil.
  • Landeiro L; Oncologia D'Or, Rio de Janeiro, RJ, Brazil.
  • Pinho JRR; Brazilian Breast Cancer Study Group (GBECAM), Porto Alegre, RS, Brazil.
  • Pulchinelli Á; Brazilian Society of Mastology, Rio de Janeiro, RJ, Brazil.
  • Ribeiro H; Santa Casa de São Paulo Hospital, São Paulo, SP, Brazil.
  • Souza R; Santa Casa de São Paulo School of Medical Sciences, São Paulo, SP, Brazil.
  • Rosa DD; Brazilian Breast Cancer Study Group (GBECAM), Porto Alegre, RS, Brazil.
JCO Glob Oncol ; 8: e2100357, 2022 05.
Article in English | MEDLINE | ID: covidwho-1862198
ABSTRACT

PURPOSE:

An expert panel on breast cancer and COVID-19 disease was convened to address the impact of the COVID-19 pandemic for early breast cancer (eBC) management.

METHODS:

To ensure that the most clinically relevant information was addressed, essential information was drawn from several of the latest national and international guidelines and another technical document. The expert panel met in five virtual closed sessions from November 2020 to May 2021 to consult on the relevant data from evidence-based results. The data gathered were discussed on an online platform.

RESULTS:

This article reports the expert panel's highlights of these meetings' discussions. In addition, it provides practical recommendations covering topics regarding diagnosis, treatment, and management of patients with eBC in clinical settings routinely encountered by health care professionals amid the COVID-19 pandemic.

CONCLUSION:

This article provided guidance on several topics regarding eBC management amid the COVID-19 pandemics to inform safer care practices.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Breast Neoplasms / COVID-19 Type of study: Diagnostic study / Experimental Studies / Prognostic study Limits: Female / Humans Language: English Journal: JCO Glob Oncol Year: 2022 Document Type: Article Affiliation country: Go.21.00357

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Breast Neoplasms / COVID-19 Type of study: Diagnostic study / Experimental Studies / Prognostic study Limits: Female / Humans Language: English Journal: JCO Glob Oncol Year: 2022 Document Type: Article Affiliation country: Go.21.00357